Advanced Regen Medical Investigation

Written by 
Published on:
November 17, 2026
Updated on:
November 17, 2026

An FDA letter in 2019 addressed to R3 Stem Cell raised concerns about how the company promoted stem cell products through its affiliated clinics. The Lyon Firm is investigating Advanced Regen Medical, a regenerative medicine clinic in Campbell, California, in light of its affiliation with R3 Stem Cell and the marketing of regenerative medicine treatments.

The Lyon Firm investigates potential consumer fraud, deceptive healthcare advertising, and misleading medical marketing. Patients who purchased treatments based on claims about their effectiveness can learn more about the firm's stem cell fraud investigation.

FDA Letter Identifies Advanced Regen Medical as an R3 Affiliate

The FDA's May 28, 2019, correspondence included a separate affiliate notification explaining that R3 Stem Cell had identified the recipient clinic as an affiliated center on its website.

The FDA's letter to R3 questioned the company's promotion of stem cell treatments for conditions including Parkinson's disease, ALS, diabetes, kidney failure, and stroke. The agency noted that these products appeared to fall under federal regulations governing human cells, tissues, and cellular and tissue-based products (HCT/Ps).

The FDA further explained that certain products promoted by R3 appeared intended for nonhomologous uses and could therefore be regulated as drugs and biological products. Such products generally require appropriate FDA approval or an effective investigational new drug application before clinical use.

The agency also raised potential safety concerns associated with unapproved treatments, including contamination risks involving products administered intravenously.

Questions About Stem Cell Advertising and Patient Disclosures

The current investigation centers on how regenerative medicine clinics communicate treatment benefits and regulatory status to prospective patients. Advanced Regen Medical advertises stem cells, exosomes, and other regenerative therapies for pain management and wellness. Its marketing references product quality and laboratory processing. Such representations warrant scrutiny when patients may interpret them as evidence of FDA approval or established clinical effectiveness.

The FDA correspondence does not establish that Advanced Regen Medical independently violated federal law, nor does it constitute a finding that the clinic's individual treatments were unlawful. However, the R3 affiliation raises questions about the marketing practices used across stem cell and wellness clinics across the country.

Patients considering expensive regenerative treatments may have limited ability to distinguish established medical evidence from promotional claims. When advertising overstates clinical benefits, consumers may have grounds to explore potential deceptive marketing claims.

The Lyon Firm represents consumers in matters involving deceptive advertising, consumer fraud, and misleading healthcare practices. The firm is investigating potential claims involving stem cell marketing and patient representations. Individuals who believe they were misled about regenerative medicine treatments can contact The Lyon Firm to discuss their experiences and learn more about taking legal action.

‍

The information presented here is based on public records, and does not constitute an allegation or conclusion of wrongdoing by Advanced Regen Medical, R3 or any other individual or entity.

Contact Us

Request a Free Consultation

Taking the first step doesn’t have to be complicated. In just a few minutes, you can share the basics of your case, and our team will guide you from there:

  • It begins with a few simple questions about your situation.
  • From there, a member of our legal team reviews your case.
  • Together, we’ll chart the path forward, helping you take the next step toward resolution.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.